​

Funding Round

Series B - Foresight Diagnostics

Series B - Foresight Diagnostics

Investment Firm

Overview

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

Announced Date

Jul 30, 2024

Closed on Date

Jul 30, 2024

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Foresite Capital

Foresite Capital

Foresite Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

5

Investor Name
Participant InvestorThe CU Healthcare Innovation Fund
Participant InvestorForesite Capital
Participant InvestorPear VC
Participant InvestorBluebird Ventures
Participant InvestorStanford University

Round Details and Background

Foresight Diagnostics raised $33000000 on 2024-07-30 in Series B

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 02, 2021
Series A - Foresight Diagnostics
3-12.5M
Apr 27, 2023
Series B - Foresight Diagnostics
7-58.8M
Sep 29, 2020
Seed Round - Foresight Diagnostics
1-undefined
Jul 30, 2024
Series B - Foresight Diagnostics
7-33.0M

Recent Activity

There is no recent news or activity for this profile.